—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
BIOCYBERNETICS AND BIOMEDICAL ENGINEERING《生物控制与生物医学工程》
季刊 - 波兰
  • BIOCYBERNETICS AND BIOMEDICAL ENGINEERING《生物控制与生物医学工程》
  • SCIE外文期刊
  • 期发文量15
  • 国人占比30.43%
  • 知网外文库,维普目次
  • 投稿方式--官网投稿
  • 期刊属性

  • 中科分区:2区
    OA期刊:混合
  • 综述期刊:
    TOP期刊:
  • 期均国文:5
    环比增速:-71.43%
  • 期刊信息

  • 研究方向:工程技术-ENGINEERING, BIOMEDICAL工程:生物医学
  • 国际刊号:ISSN: 0208-5216;E-ISSN: 0208-5216
  • 期刊语言:英语
    出版地区:波兰
  • 投稿网址:https://www.editorialmanager.com/BBE/default.aspx
  • 电子邮箱:
  • 期刊官网:https://www.journals.elsevier.com/biocybernetics-and-biomedical-engineering
  • 作者指南:
  • 出版商网址:http://www.elsevier.com
  • 出版地址:ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE
  • 期刊简介:BIOCYBERNETICS AND BIOMEDICAL ENGINEERING《生物控制与生物医学工程》(季刊). Biocybernetics and Biomedical Engineering is a quarterly journal, founded in 1981, devoted to publishing the results of original, innovative and creative research investigations in the field of Biocybernetics and biomedical engineering, which bridges mathematical, physical, chemical and engineering methods and technology to analyse physiological processes in living organisms as well as to develop methods, devices and systems used in biology and medicine, mainly in medical diagnosis, monitoring systems and therapy. The Journals mission is to advance scientific discovery into new or improved standards of care, and promotion a wide-ranging exchange between science and its application to humans.

  • 万维提示



  • 1、投稿方式:在线投稿。

    2、期刊网址:

    https://www.journals.elsevier.com/biocybernetics-and-biomedical-engineering

    https://www.sciencedirect.com/journal/biocybernetics-and-biomedical-engineering

    3、投稿网址:

    https://www.editorialmanager.com/BBE/default.aspx

    4、官网邮箱:bbe@elsevier.com(编辑部)

    5、期刊刊期:季刊,一年出版4期。

    2021年121日星期三

                              

     

    投稿须知【官网信息】

     

    Guide for Authors

    Aims and scope

    Biocybernetics and Biomedical Engineering is a quarterly journal, founded in 1981, devoted to publishing the results of original, innovative and creative research investigations in the field of Biocybernetics and biomedical engineering, which bridges mathematical, physical, chemical and engineering methods and technology to analyse physiological processes in living organisms as well as to develop methods, devices and systems used in biology and medicine, mainly in medical diagnosis, monitoring systems and therapy. The Journal's mission is to advance scientific discovery into new or improved standards of care, and promotion a wide-ranging exchange between science and its application to humans. Biocybernetics and Biomedical Engineering encourages contributions on all aspects of research and developments in: biosystems, including biomedical modeling; cell and tissue engineering for repair medicine; biomeasurements, including biosignal processing and biosensing systems; artificial and hybrid (bioartificial) organs; biomaterials; biomechanics and rehabilitation, including orthopedics and sports medicine; medical information systems and neuronal networks; information and communication technologies in medicine, including brain-computer interfaces; medical imaging, including brain functional magnetic resonance imaging (fMRI); bioinformatics, including genome analysis; and medical physics.

    The journal welcomes original research articles, reviews and short communications.

    Biocybernetics and Biomedical Engineering (BBE) is the official journal of the Nalecz Institute of Biocybernetics and Biomedical Engineering of the Polish Academy of Sciences.

    Please see our Guide for Authors for information on article submission.

    Benefits to authors

    We also provide many author benefits, such as free PDFs, special discounts on Elsevier publications and much more. Please click here for more information on our author services .

    Manuscripts should be submitted via online system EM at https://www.editorialmanager.com/BBE.

    Criteria for manuscripts

    The Editorial Board of Biocybernetics and Biomedical Engineering takes under consideration for publication original articles with the understanding that neither the manuscript nor any part of its essential substance, tables or figures have been published previously in print form or electronically and are not under consideration by any other publication or electronic medium. Copies of any closely related manuscripts should be submitted to the Editor along with the manuscript that is to be considered by Biocybernetics and Biomedical Engineering. Each submission packet should include the statement signed by the first author that the work has not been published previously or submitted elsewhere for review and a copyright transfer.

    For papers exceeding 12 typeset pages (approx. 25 pages of a manuscript/ 26 500 characters without spaces, including tables and figures), an excess-page charge per printed page may apply: 103 EUR net for pages 13 et seq. The author(s) will be informed whether or not his/her/their paper has been accepted for printing and will be billed for the excess-page charge (if any). The charge is up to Editor-in-Chief's decision.

    For articles exceeding the limit please contact the editorial office at bbe@elsevier.com.

    Submission checklist

    You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.

    Ensure that the following items are present:

    One author has been designated as the corresponding author with contact details:

    E-mail address

    Full postal address

    All necessary files have been uploaded:

    Manuscript:

    Include keywords

    All figures (include relevant captions)

    All tables (including titles, description, footnotes)

    Ensure all figure and table citations in the text match the files provided

    Indicate clearly if color should be used for any figures in print

    Graphical Abstracts / Highlights files (where applicable)

    Supplemental files (where applicable)

    Further considerations

    Manuscript has been 'spell checked' and 'grammar checked'

    All references mentioned in the Reference List are cited in the text, and vice versa

    Permission has been obtained for use of copyrighted material from other sources (including the Internet)

    A competing interests statement is provided, even if the authors have no competing interests to declare

    Journal policies detailed in this guide have been reviewed

    ……

    更多详情:

    https://www.elsevier.com/journals/biocybernetics-and-biomedical-engineering/0208-5216/guide-for-authors




欢迎点评!让信息更透明,使投稿更轻松!
  • 审稿时间:
    是否录用:
  • 见刊周期:
    查重要求:
  • 有无课题:
    有无回复:
  • 我的学历:
    我的职称:
  • 审稿费用:
    版面费用:
  • 稿       费:
    稿件字数:
  • 投稿难度:
  • 该刊可发:
  • 投稿主题:
匿名: 验证码: 点击切换验证码
    评分:0

    验证码: 点击切换验证码